Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Zhonghua Yi Xue Za Zhi ; 83(15): 1303-5, 2003 Aug 10.
Artigo em Chinês | MEDLINE | ID: mdl-12930682

RESUMO

OBJECTIVE: To study the relationship of the long-term incidence rate of benign prostate hyperplasia (BPH) after vasectomy to age and time after operation. METHOD: Questionnaire survey, physical examination, and ultrasonography were conducted among 850 healthy males, aged 55 - 76 who underwent vasectomy more than 20 years before and 390 healthy males, aged 53 - 75, who had not undergone vasectomy in Yichang, Hubei province, selected by randomized cluster sampling. The data such as international prostate symptom scoring (IPSS), quality of life (QOL) index, maximum urine flow rate (MFR), and average flow rate (AFR), digital rectal examination (DRE), volume of prostate gland (V), and residual urine (R) were analyzed. RESULTS: The general BPH incidence rate of the vasectomy group was 10.8%, significantly lower than that of the control group (40.8%, P < 0.01). The age-specific BPH incidence rates in the vasetomy group were all significantly lower than those of the control group, especially that of the subjects aged over 70 (10.8% vs. 56.5%, P < 0.001). The BPH incidence rate of those who had undergone vasectomy 25 years or over before was 7.8%, significantly lower than that of those who had undergone vasectomy 20 years before (13.2%, P < 0.05), but not significantly difference from that of those who had undergone vasectomy 30 years or over before (5.5%, P > 0.05). The volumes of prostate gland in all age subgroups were significantly smaller in the vasectomy group than in the control group. CONCLUSION: Vasectomy reduces the incidence rate of BPH significantly.


Assuntos
Hiperplasia Prostática/epidemiologia , Vasectomia , Fatores Etários , Idoso , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Fatores de Tempo
2.
Zhonghua Nan Ke Xue ; 9(1): 20-3, 2003 Feb.
Artigo em Chinês | MEDLINE | ID: mdl-12680325

RESUMO

OBJECTIVES: To investigate the possibility and efficacy of vasoligation and deferent vein ligation in treating and preventing benign prostatic hyperplasia(BPH). METHODS: 40 male pooches were divided into A, B, C and D groups randomly. Each group has 10 pooches group A and B were made into the model of BPH. Two years later, the pooches in group A and C accepted the operation of vasoligation and deferent vein ligation on both sides. Group B and D only accepted the operation of dissection and relieving its deferent duct. Then continuing to feed the 40 pooches after the operation, they were killed another two years later. After taking out their prostates and calculating their volume and weight, the sections of the prostates were checked by microscope to observe their histology and pathology changes. RESULTS: There were significant differences of weight and volume as well as the changes of histology and pathology between group A and group C (P < 0.01). It was the same with group B and D (hyperplasia changes). CONCLUSIONS: Vasoligation and deferent vein ligation before benign prostatic hyperplasia at pooches grow-up stage can reduce the extent of BPH at old age, and treatment after benign prostatic hyperplasia can make prostatic tissue appear different degrees of atrophy.


Assuntos
Hiperplasia Prostática/terapia , Vasectomia , Animais , Modelos Animais de Doenças , Cães , Ligadura , Masculino , Hiperplasia Prostática/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA